Vitro Biopharma, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Vitro Biopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2010 to Q2 2024.
  • Vitro Biopharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending July 31, 2024 was 4.46M shares, a 0.68% increase year-over-year.
  • Vitro Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 4.43M shares, a 6.91% increase from 2022.
  • Vitro Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 4.14M shares.
  • Vitro Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2014 was 19.9M shares, a 1.49% increase from 2013.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 4.46M +30K +0.68% May 1, 2024 Jul 31, 2024 10-Q 2024-09-16
Q1 2024 4.46M +30K +0.68% Feb 1, 2024 Apr 30, 2024 10-Q 2024-05-31
Q4 2023 4.46M +24.8K +0.56% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-14
Q3 2023 4.43M Aug 1, 2023 Oct 31, 2023 10-K 2024-01-29
Q2 2023 4.43M -10 0% May 1, 2023 Jul 31, 2023 10-Q 2024-09-16
Q1 2023 4.43M Feb 1, 2023 Apr 30, 2023 10-Q 2024-05-31
Q4 2022 4.43M Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-14
Q2 2022 4.43M May 1, 2022 Jul 31, 2022 10-Q 2023-08-28
Q4 2014 20M +168K +0.85% Nov 1, 2014 Jan 31, 2015 10-Q 2015-03-24
Q1 2014 19.8M +326K +1.67% Feb 1, 2014 Apr 30, 2014 10-Q 2014-06-19
Q4 2013 19.8M Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-24
Q1 2013 19.5M +644K +3.41% Feb 1, 2013 Apr 30, 2013 10-Q 2014-06-19
Q3 2012 19M +540K +2.93% Aug 1, 2012 Oct 31, 2012 10-K 2014-02-12
Q2 2012 19.3M +741K +4% May 1, 2012 Jul 31, 2012 10-Q/A 2012-10-17
Q1 2012 18.9M +422K +2.29% Feb 1, 2012 Apr 30, 2012 10-Q/A 2012-06-22
Q4 2011 18.5M +149K +0.81% Nov 1, 2011 Jan 31, 2012 10-Q 2012-03-21
Q3 2011 18.5M Aug 1, 2011 Oct 31, 2011 10-K/A 2012-02-16
Q2 2011 18.5M +570K +3.18% May 1, 2011 Jul 31, 2011 10-Q/A 2012-10-17
Q1 2011 18.4M Feb 1, 2011 Apr 30, 2011 10-Q/A 2012-06-22
Q4 2010 18.4M Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-21
Q2 2010 17.9M May 1, 2010 Jul 31, 2010 10-Q/A 2011-10-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.